Altamira Therapeutics Ltd. Gains 59.09%
Wed, Apr 12, 2023 at 07:07 PM
Altamira Therapeutics Ltd. (CYTO:NASDAQ) shot up at $2.1, representing a gain of 59.1%. On Wed, Apr 12, 2023, CYTO:NASDAQ hit a New 2-Week High of $2.1. The stock got featured on our News Catalysts scanner on Wed, Apr 12, 2023 at 09:37 AM in the 'BIOTECH' category. From Wed, Mar 29, 2023, the stock recorded 77.78% Up Days and 70.00% Green Days
The stock spiked on Fri, Oct 21, 2022 at $13.52 with a volume of 3M+.
About Altamira Therapeutics Ltd. (CYTO:NASDAQ)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
Top 10 Gainers:
- National CineMedia, Inc. (NCMI:NASDAQ), 114.6%
- Guardforce AI Co. Limited (GFAI:NASDAQ), 88.72%
- TESSCO Technologies Incorporated (TESS:NASDAQ), 87.02%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 59.09%
- Heartcore Enterprises Inc. (HTCR:NASDAQ), 56.86%
- Bullfrog AI Holdings Inc. (BFRG:NASDAQ), 42.23%
- Jowell Global Ltd. (JWEL:NASDAQ), 41.67%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 40%
- Charah Solutions, Inc. (CHRA:NYSE), 38.24%
- GlucoTrack Inc. (GCTK:NASDAQ), 37.76%